Dr. Amour is a physician scientist at the Muhimbili University of Health, and Allied Sciences (MUHAS), Tanzania. She graduated from MUHAS and holds a Master degree in public health from the Dartmouth Institute for Health Policy and Clinical Practice in USA. Currently, Dr. Amour is a postdoctoral fellow at the Harvard School of Public Health. Her professional interests are on infectious diseases, particularly COVID-19, TB/HIV, and adolescents’ health.
Dr. Amour has been actively involved in TB and HIV research among adolescents in Tanzania. She is currently the principal investigator in a research study examining TB infection by serial Interferon gamma release assay testing among adolescents and their household contacts. Previously, she served as a co-investigator in a TB vaccine clinical trial for prevention of tuberculosis infection among adolescents in Tanzania. She then served as member of the National Immunization Technical Advisory Group (NITAG) in Tanzania. Dr. Amour has also conducted epidemiological studies among adolescents living with HIV. For the past two years, she has been consulting in enhancing country analytical capacity and data use in HIV, TB, and Malaria programs under the Global Fund support.
Ever since the COVID-19 pandemic, she has been involved in advocacy and educating the public through different platforms on COVID-19 and COVID-19 vaccines. Recently, she was a principal investigator in a nationwide study examining the acceptance of COVID-19 vaccine among health care workers and communities in Tanzania. For her work, Dr Amour was nominated in the 2021 cohort of young physician leaders.
Dr. Amour is a member of the Medical Women Association of Tanzania (MEWATA) and has been actively participating in organizing nationwide mass screening campaigns of breast and cervical cancer since 2012. Dr. Amour has also been involved in strengthening the capacity of civil society organisations (CSOs) dealing with entrepreneurship, climate change, women rights, and gender-based violence prevention in Tanzania.
